2021 - Present | Adjunct Associate Professor, Baylor College of Medicine | |
|
||
2021 - Present | Professor of Medicine, University of Houston | |
|
||
2021 - Present | Program Director, Internal Medicine, HCA Houston Healthcare Kingwood, HCA Healthcare ‐ HCA Houston Healthcare Kingwood | |
|
||
2016 - 2021 | Associate Professor of Medicine, Baylor College of Medicine | |
|
||
2010 - 2016 | Assistant Professor of Medicine, Baylor College of Medicine | |
|
Disciplines
Research Interests
Grants
2019 - Present | DUPLEX: Page 3 Trial for Sparsenten in Primary Focal Segmental Glomerulosclerosis |
Retrophin | |
Role: Principal Investigator | |
2020 - 2020 | Kidney Diet Challenge |
BCM Education Grant | |
Role: Principal Investigator | |
$900 | |
2018 - 2019 | Phase 2 Trial for 6 months for patients with C3 Glomerulopathy |
Achillion - ACH471-204 | |
Role: Principal Investigator | |
2017 - 2018 | Difficult Conversations in Nephrology: Communications Workshop |
BCM Education Grant | |
Role: Principal Investigator | |
$1,200 | |
2013 - 2015 | ATLAS: Proof-of-Concept Study to study BIIB-023 in patients with active lupus nephritis |
Biogen | |
Role: Principal Investigator | |
2011 - 2014 | ChART: A Randomized, Placebo-controlled, parallel-group, double-blind study for H.P. ACTHar gel in Treatment Resistant Subjects with Persistent Proteinuria and Nephrotic Syndrome due to Idiopathic Membranous Nephropathy |
Questcor | |
Role: Principal Investigator | |
2011 - 2013 | REAL-ICU: A multi-center study to evaluate the NGAL marker in patients admitted to the ICU |
Alere | |
Role: Principal Investigator | |
2010 - 2012 | A multi-center, randomized, double-blind, active-controlled clinical trial to evaluate the safety and tolerability of 24 weeks treatment with Vildagliptin (50 mg) versus Sitagliptin (25 mg) in patients with type 2 diabetes and severe renal insufficiency |
Novartis | |
Role: Sub-Investigator | |
2005 - 2005 | Patient-Reported Religiosity and Outcome of Treatment for Hepatitis C |
Frank Lanza and Gulf Coast Digestive Disease Fund | |
Role: Fellow Investigator | |
Colleague(s): Richard Goodgame, MD | |
2002 - 2002 | Retrospective Analysis of Patients in a Long Term Care Service |
American Federation on Aging Research | |
Role: Fellow Investigator | |
Colleague(s): Wayne McCormick, MD |
Professional Service and Affiliations
2013 - Present | Fellow, American Society of Nephrology | Present | Member, American College of Physicians | Present | Member, Harris County Medical Society | Present | Member, Texas Medical Society |
Honors and Awards
- Case Western Reserve University College of Engineering Connie Elcin Award to the Most Outstanding Senior in Chemical Engineering: May 2001
- John McGovern Museum of Medical Health and Science. Neuroscience Instructor: November 2004
- Texas Rising Stars – Voted by peer review, best physicians in Texas: June 2013
- Baylor ICTR Clinical Investigator Award: Quarter 2, March 2014
- “You First!” Nephrology section for highest score in patient satisfaction: April 2014
- Fulbright & Jaworski Award (BCM) for Teaching and Evaluation: April 2014
- Named to Peer-Reviewed America’s Best Physicians: October 2015, 2016, 2017, 2018
- POP - Professionalism Award, Baylor College of Medicine Centers for Professionalism: February 2017
- “That’s The Way 10k Award” Nephrology section award for most improvement in patient satisfaction: May 2017
- Star Award for Excellence in Patient Care (BCM) – February 2019
- Alpha Omega Alpha 2019 Graduating Medical Student Class Inductee (6 awardees
- Norton Rose Fulbright Award (BCM) for Educational Leadership: July 2019
- Houstonia Top Physicians: January 2021
- “That’s The Way” Top Physician at BCM by Press Ganey (BCM): May 2021
- “Physician of the Quarter” at HCA Kingwood: January 2022
2019 - 2021 | Master of Education, University of Houston | |
|
||
2008 - 2010 | Fellowship, Nephrology, Baylor College of Medicine | |
|
||
2005 - 2008 | Residency, Internal Medicine, Baylor College of Medicine | |
|
||
2005 | MD, Baylor College of Medicine | |
|